IP Library › Granted Patent US 12,624,283
Granted Patent B2
US 12,624,283 · App. 17/754,783 · Granted May 12, 2026

Blue to UV up-converter comprising lanthanide ions such as Pr3+ activated and optionally Gd3+ co-activated silicates and its application for surface disinfection purposes

Inventors: Stefan Fischer (Soest, DE); David Böhnisch (Kirchheim am Neckar, DE); Thomas Jüstel (Witten, DE); Simone Schulte (Essen, DE); Markus Hallack (Schermbeck, DE)
Assignee: Evonik Operations GmbH
C09K11/77742C09K11/77062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,624,283
App. No.
17/754,783
Granted
May 12, 2026
Kind
B2
Abstract

A silicate-based lanthanide ion doped material converts electromagnetic radiation energy of a longer wavelength of below 530 nm to electromagnetic radiation energy of shorter wavelengths in the range of 220 to 425 nm. The silicate-based material is a crystalline silicate material doped with lanthanide ions selected from praseodymium, gadolinium, erbium, and neodymium. For co-doping, at least two of the lanthanide ions are used. The silicate-based material is obtainable from a blend comprising salts and an organic solvent, followed by specific calcination processes and tribological impacts to adjust particle size and to increase the crystallinity of the particles. The silicate-based material can be used to inactivate microorganisms or cells covering a surface containing the silicate-based material under exposure of electromagnetic radiation energy of a longer wavelength of below 500 nm.

Claims (36)

1 . A silicate-based material, comprising:

a crystalline silicate material doped with at least one lanthanide ion selected from the group consisting of praseodymium, gadolinium, and

wherein the crystalline silicate material converts electromagnetic radiation energy of at least one longer wavelength in a range of 380-550 nm electromagnetic radiation energy of at least one shorter wavelength in a range of 220 to 425 nm, wherein the at least one longer wavelength has a longer wavelength than the at least one shorter wavelength;

wherein the crystalline silicate material is selected from the general formula I

A 1-x-y-z B* y B 2 SiO 4 :Ln 1 x ,Ln 2 z .  I

wherein x=0.0001-0.05, z=0 or z=0.0001 to 0.3, and y=x+z,

wherein A is selected from the group consisting of Mg, Ca, Sr and Ba,

wherein B is selected from the group consisting of Li, Na, K, Rb and Cs,

wherein B* is selected from the group consisting of Li, Na and K, wherein B equal to B* or B being not equal to B*,

Ln 1 is praseodymium (Pr), and

Ln 2 is gadolinium (Gd).

2 . The silicate-based material according to claim 1 , wherein the crystalline silicate material is not a hydrate of a silicate.

3 . The silicate-based material according to claim 1 , wherein a crystallinity of the silicate-based material is greater than 70%.

4 . The silicate-based material according to claim 1 , wherein the crystalline silicate material comprises:

a crystalline pure phase, or

a silica-based material comprising at least one crystal phase that encompasses at least 90 weight-% of the silica-based material.

5 . The silicate-based material according to claim 1 , wherein the crystalline silicate material is a solid solution of a crystalline silicate or of crystalline silicate doped with lanthanide ions comprising at least one alkali ion and at least one earth alkali ion.

6 . A process for the production of a silicate-based material, the process comprising:

combining the following components i), ii), and iii),

i) and/or lanthanide oxide,

wherein a lanthanide ion in the at least one lanthanide salt and/or lanthanide oxide is selected from the group consisting of praseodymium, gadolinium, erbium, and neodymium,

ii) a silicate, and

iii) at least one earth alkali salt and at least one alkali salt selected from the group consisting of a lithium salt, a lithium compound, a sodium salt, and a potassium salt,

wherein the combining comprises:

a) blending i), ii), and iii) by milling, and obtaining a mixture, or

b) blending i), ii), and iii) in an organic polar or non-polar solvent that is not a protic solvent, and obtaining a mixture, wherein the obtained mixture of b) is calcinated at 600° C. to 1000° C. to remove organic components, and to obtain a calcinated mixture,

performing a calcination of the mixture of a) or the calcinated mixture of b) in a calcination at a temperature below a melting temperature of the silicate-based material, wherein at least partial crystallization occurs, and

performing a further calcination under a reducing atmosphere, wherein the lanthanide ion is reduced to an Ln 3+ ion, and

obtaining the silicate-based material,

wherein the obtained silicate-based material is milled, and

wherein the obtained silicate-based material is subjected to tribological impacts at 100 to 500 rotations/min for 1 to 6 hours, using corundum as milling material.

7 . A composition, foil or film, comprising the silicate-based material according to claim 1 for self-disinfection purposes or for reduction of microorganisms.

8 . A method, comprising:

adding the silicate-based material according to claim 1 into a coating composition or a material to provide a coating or surface that is able to inactivate microorganisms covering the coating or surface under exposure of electromagnetic radiation energy of a longer wavelength in a range of 500 nm and below.

9 . The silicate-based material according to claim 1 , wherein an emission maximum of the electromagnetic radiation energy of the shorter wavelengths has an intensity of at least 1⋅10 3 counts/(mm 2 *s).

10 . The silicate-based material according to claim 1 , wherein in formula I, B and B* are not equal.

Priority Claims (1)
EP 19202910 · Oct 14, 2019 · regional
Continuity (1)
Related Publication 20220403239A1 · Dec 22, 2022
References Cited (79)
US 4963787A · Verlijsdonk et al. · 1990 [cited by applicant]
US 6794445B2 · Reusmann et al. · 2004 [cited by applicant]
US 7535009B2 · Juestel et al. · 2009 [cited by applicant]
US 7902564B2 · Mueller-Mach et al. · 2011 [cited by applicant]
US 8617422B2 · Koschan et al. · 2013 [cited by applicant]
US 9266825B2 · Lomoelder et al. · 2016 [cited by applicant]
US 9796876B2 · Lomoelder et al. · 2017 [cited by applicant]
US 9902095B2 · Stapperfenne et al. · 2018 [cited by applicant]
US 9902096B2 · Stapperfenne et al. · 2018 [cited by applicant]
US 10100207B2 · Stache et al. · 2018 [cited by applicant]
US 10239898B2 · Hallack et al. · 2019 [cited by applicant]
US 10626291B2 · Hallack et al. · 2020 [cited by applicant]
US 10633555B2 · Stache et al. · 2020 [cited by applicant]
US 11021608B2 · Seyfried et al. · 2021 [cited by applicant]
US 11254819B2 · Hallack et al. · 2022 [cited by applicant]
US 11713400B2 · Schulte · 2023 [cited by examiner]
US 20030198819A1 · Reusmann et al. · 2003 [cited by applicant]
US 20060022146A1 · Juestel et al. · 2006 [cited by applicant]
US 20060108910A1 · Justel · 2006 [cited by examiner]
US 20070203307A1 · Cavaleiro et al. · 2007 [cited by applicant]
US 20100297206A1 · Kim et al. · 2010 [cited by applicant]
US 20130052079A1 · Bernstein · 2013 [cited by applicant]
US 20130207002A1 · Greuel et al. · 2013 [cited by applicant]
US 20130224071A1 · Bernstein · 2013 [cited by examiner]
US 20150191625A1 · Lomoelder et al. · 2015 [cited by applicant]
US 20150225337A1 · Lomoelder et al. · 2015 [cited by applicant]
US 20150321392A1 · Stapperfenne et al. · 2015 [cited by applicant]
US 20150321393A1 · Stapperfenne et al. · 2015 [cited by applicant]
US 20160017165A1 · Numrich et al. · 2016 [cited by applicant]
US 20160108280A1 · Hallack et al. · 2016 [cited by applicant]
US 20160297974A1 · Stache et al. · 2016 [cited by applicant]
US 20170298250A1 · Anselmann et al. · 2017 [cited by applicant]
US 20180179234A1 · Hallack et al. · 2018 [cited by applicant]
US 20190048224A1 · Stache et al. · 2019 [cited by applicant]
US 20190241741A1 · Seyfried et al. · 2019 [cited by applicant]
US 20200308406A1 · Seyfried et al. · 2020 [cited by applicant]
US 20210122921A1 · Hallack et al. · 2021 [cited by applicant]
US 20210253889A1 · Schulte et al. · 2021 [cited by applicant]
US 20210403753A1 · Schulte et al. · 2021 [cited by applicant]
US 20220041887A1 · Roland et al. · 2022 [cited by applicant]
US 20220049362A1 · Hallack et al. · 2022 [cited by applicant]
CN 103421504 · 2013 [cited by applicant]
JP H02247279 · 1990 [cited by applicant]
JP 2005536736 · 2005 [cited by applicant]
JP 2005536843 · 2005 [cited by applicant]
JP 2010270117 · 2010 [cited by applicant]
JP 2014500890 · 2014 [cited by applicant]
JP 2016121326 · 2016 [cited by applicant]
WO 2014135353 · 2014 [cited by applicant]
International Search Report mailed Jan. 19, 2021 in PCT/EP2020/077798, 4 pages. [cited by applicant]
Written Opinion mailed Jan. 19, 2021 in PCT/EP2020/077798, 7 pages. [cited by applicant]
Naumann et al., U.S. Appl. No. 18/554,976, filed Oct. 11, 2023. [cited by applicant]
Naumann et al., U.S. Appl. No. 18/555,015, filed Oct. 12, 2023. [cited by applicant]
U.S. Appl. No. 18/554,976, filed Oct. 11, 2023, Naumann et al. [cited by applicant]
U.S. Appl. No. 18/555,015, filed Oct. 12, 2023, Naumann et al. [cited by applicant]
Extended European Search Report dated May 19, 2020, in European Patent Application No. 19202910.6, 8 pages. [cited by applicant]
Madsen et al., “Description and survey of methodologies for the determination of amorphous content via X-ray powder diffraction”, Z. Kristallogr., vol. 226, 2011, pp. 944-955. [cited by applicant]
Madsen et al., “Quantifying Amorphous Phases”, Bruker, document presented at PPXRD-Pharmaceutical Powder X ray Diffraction Symposium, 55 pages. [cited by applicant]
Pecharsky et al., “The Powder Diffraction Pattern”, Fundamentals of Powder Diffraction and Structural Characterization of Materials, Chapter 8, pp. 151-202. [cited by applicant]
U.S. Pat. No. 6,794,445, Sep. 21, 2004, 2003/0198819, Reusmann et al. [cited by applicant]
U.S. Appl. No. 11/677,821, filed Feb. 22, 2007, 2007/0203307, Cavaleiro et al. [cited by applicant]
U.S. Pat. No. 9,796,876, filed Oct. 24, 2017, 2015/0191625, Lomoelder et al. [cited by applicant]
U.S. Pat. No. 10,626,291, Apr. 21, 2020, 2016/0108280, Hallack et al. [cited by applicant]
U.S. Appl. No. 14/772,019, filed Sep. 1, 2015, 2016/0017165, Numrich et al. [cited by applicant]
U.S. Pat. No. 9,266,825, Feb. 23, 2016, 2015/0225337, Lomoelder et al. [cited by applicant]
U.S. Pat. No. 10,239,898, Mar. 26, 2019, 2018/0179234, Hallack et al. [cited by applicant]
U.S. Pat. No. 9,902,095, Feb. 27, 2018, 2015/0321392, Stapperfenne et al. [cited by applicant]
U.S. Pat. No. 9,902,096, Feb. 27, 2018, 2015/0321393, Stapperfenne et al. [cited by applicant]
U.S. Appl. No. 15/510,282, filed Mar. 10, 2017, 2017/0298250, Anselmann et al. [cited by applicant]
U.S. Pat. No. 10,100,207, Oct. 16, 2018, 2016/0297974, Stache et al. [cited by applicant]
U.S. Pat. No. 10,633,555, Apr. 28, 2020, 2019/0048224, Stache et al. [cited by applicant]
U.S. Pat. No. 11,021,608, Jun. 1, 2021, 2019/0241741, Seyfried et al. [cited by applicant]
U.S. Appl. No. 16/834,781, filed Mar. 30, 2020, 2020/0308406, Seyfried et al. [cited by applicant]
U.S. Appl. No. 17/176,922, filed Feb. 16, 2021, 2021/0253889, Schulte et al. [cited by applicant]
U.S. Appl. No. 17/754,777, filed Apr. 12, 2022, Fischer et al. [cited by applicant]
U.S. Pat. No. 11,254,819, Feb. 22, 2022, 2021/0122921, Hallack et al. [cited by applicant]
U.S. Appl. No. 17/395,616, filed Aug. 6, 2021, 2022/0041887, Roland et al. [cited by applicant]
U.S. Appl. No. 17/355,385, filed Jun. 23, 2021, 2021/0403753, Schulte et al. [cited by applicant]
U.S. Appl. No. 17/399,171, filed Aug. 11, 2021, 2022/0049362, Hallack et al. [cited by applicant]